These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

435 related items for PubMed ID: 30690103

  • 1. Functional assessment of peptide-modified PLGA nanoparticles against oral biofilms in a murine model of periodontitis.
    Mahmoud MY, Steinbach-Rankins JM, Demuth DR.
    J Control Release; 2019 Mar 10; 297():3-13. PubMed ID: 30690103
    [Abstract] [Full Text] [Related]

  • 2. Peptide-modified nanoparticles inhibit formation of Porphyromonas gingivalis biofilms with Streptococcus gordonii.
    Kalia P, Jain A, Radha Krishnan R, Demuth DR, Steinbach-Rankins JM.
    Int J Nanomedicine; 2017 Mar 10; 12():4553-4562. PubMed ID: 28790818
    [Abstract] [Full Text] [Related]

  • 3. BAR-encapsulated nanoparticles for the inhibition and disruption of Porphyromonas gingivalis-Streptococcus gordonii biofilms.
    Mahmoud MY, Demuth DR, Steinbach-Rankins JM.
    J Nanobiotechnology; 2018 Sep 15; 16(1):69. PubMed ID: 30219060
    [Abstract] [Full Text] [Related]

  • 4. Structural dissection and in vivo effectiveness of a peptide inhibitor of Porphyromonas gingivalis adherence to Streptococcus gordonii.
    Daep CA, Novak EA, Lamont RJ, Demuth DR.
    Infect Immun; 2011 Jan 15; 79(1):67-74. PubMed ID: 21041492
    [Abstract] [Full Text] [Related]

  • 5. In Vitro and In Vivo Activity of Peptidomimetic Compounds That Target the Periodontal Pathogen Porphyromonas gingivalis.
    Tan J, Patil PC, Luzzio FA, Demuth DR.
    Antimicrob Agents Chemother; 2018 Jul 15; 62(7):. PubMed ID: 29760142
    [Abstract] [Full Text] [Related]

  • 6. Selective substitution of amino acids limits proteolytic cleavage and improves the bioactivity of an anti-biofilm peptide that targets the periodontal pathogen, Porphyromonas gingivalis.
    Daep CA, Novak EA, Lamont RJ, Demuth DR.
    Peptides; 2010 Dec 15; 31(12):2173-8. PubMed ID: 20800634
    [Abstract] [Full Text] [Related]

  • 7. Structural characterization of peptide-mediated inhibition of Porphyromonas gingivalis biofilm formation.
    Daep CA, James DM, Lamont RJ, Demuth DR.
    Infect Immun; 2006 Oct 15; 74(10):5756-62. PubMed ID: 16988253
    [Abstract] [Full Text] [Related]

  • 8. New Application of Psoralen and Angelicin on Periodontitis With Anti-bacterial, Anti-inflammatory, and Osteogenesis Effects.
    Li X, Yu C, Hu Y, Xia X, Liao Y, Zhang J, Chen H, Lu W, Zhou W, Song Z.
    Front Cell Infect Microbiol; 2018 Oct 15; 8():178. PubMed ID: 29922598
    [Abstract] [Full Text] [Related]

  • 9. Rapid Release Polymeric Fibers for Inhibition of Porphyromonas gingivalis Adherence to Streptococcus gordonii.
    Mahmoud MY, Sapare S, Curry KC, Demuth DR, Steinbach-Rankins JM.
    Front Chem; 2019 Oct 15; 7():926. PubMed ID: 32039149
    [Abstract] [Full Text] [Related]

  • 10. Targeting the HUβ Protein Prevents Porphyromonas gingivalis from Entering into Preexisting Biofilms.
    Rocco CJ, Bakaletz LO, Goodman SD.
    J Bacteriol; 2018 Jun 01; 200(11):. PubMed ID: 29437850
    [Abstract] [Full Text] [Related]

  • 11. Spent culture supernatant of Streptococcus gordonii mitigates inflammation of human periodontal cells and inhibits proliferation of pathogenic oral microbes.
    Shu Y, Upara C, Ding Q, Zhu M, Zeng E, Banas JA, Hong L.
    J Periodontol; 2023 Apr 01; 94(4):575-585. PubMed ID: 36369979
    [Abstract] [Full Text] [Related]

  • 12. Melatonin Receptor Agonists as the "Perioceutics" Agents for Periodontal Disease through Modulation of Porphyromonas gingivalis Virulence and Inflammatory Response.
    Zhou W, Zhang X, Zhu CL, He ZY, Liang JP, Song ZC.
    PLoS One; 2016 Apr 01; 11(11):e0166442. PubMed ID: 27832188
    [Abstract] [Full Text] [Related]

  • 13. Tobacco smoke augments Porphyromonas gingivalis-Streptococcus gordonii biofilm formation.
    Bagaitkar J, Daep CA, Patel CK, Renaud DE, Demuth DR, Scott DA.
    PLoS One; 2011 Apr 01; 6(11):e27386. PubMed ID: 22110637
    [Abstract] [Full Text] [Related]

  • 14. Experimental Inoculation of Aggregatibacter actinomycetemcomitans and Streptococcus gordonii and Its Impact on Alveolar Bone Loss and Oral and Gut Microbiomes.
    Rocha CM, Kawamoto D, Martins FH, Bueno MR, Ishikawa KH, Ando-Suguimoto ES, Carlucci AR, Arroteia LS, Casarin RV, Saraiva L, Simionato MRL, Mayer MPA.
    Int J Mol Sci; 2024 Jul 25; 25(15):. PubMed ID: 39125663
    [Abstract] [Full Text] [Related]

  • 15. Identification of Small-Molecule Inhibitors Targeting Porphyromonas gingivalis Interspecies Adherence and Determination of Their In Vitro and In Vivo Efficacies.
    Roky M, Tan J, Sztukowska MN, Trent JO, Demuth DR.
    Antimicrob Agents Chemother; 2020 Oct 20; 64(11):. PubMed ID: 32816725
    [Abstract] [Full Text] [Related]

  • 16. Role of gallium and silver from phosphate-based glasses on in vitro dual species oral biofilm models of Porphyromonas gingivalis and Streptococcus gordonii.
    Valappil SP, Coombes M, Wright L, Owens GJ, Lynch RJ, Hope CK, Higham SM.
    Acta Biomater; 2012 May 20; 8(5):1957-65. PubMed ID: 22314314
    [Abstract] [Full Text] [Related]

  • 17. The Effects of Antimicrobial Peptide Nal-P-113 on Inhibiting Periodontal Pathogens and Improving Periodontal Status.
    Wang H, Ai L, Zhang Y, Cheng J, Yu H, Li C, Zhang D, Pan Y, Lin L.
    Biomed Res Int; 2018 May 20; 2018():1805793. PubMed ID: 29736391
    [Abstract] [Full Text] [Related]

  • 18. Characterization and development of SAPP as a specific peptidic inhibitor that targets Porphyromonas gingivalis.
    Ho MH, Lamont RJ, Chazin WJ, Chen H, Young DF, Kumar P, Xie H.
    Mol Oral Microbiol; 2018 Dec 20; 33(6):430-439. PubMed ID: 30298683
    [Abstract] [Full Text] [Related]

  • 19. Streptococcus cristatus ArcA interferes with Porphyromonas gingivalis pathogenicity in mice.
    Xie H, Hong J, Sharma A, Wang BY.
    J Periodontal Res; 2012 Oct 20; 47(5):578-83. PubMed ID: 22448761
    [Abstract] [Full Text] [Related]

  • 20. Assessment of CafA Targeted BAR-Encapsulated Nanoparticles against Oral Biofilms.
    Desai H, Mahmoud MY, Tan J, Minooei F, Demuth DR, Steinbach-Rankins JM.
    Pharmaceutics; 2020 Sep 01; 12(9):. PubMed ID: 32882864
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.